Tampere University Hospital Catchment Area

Medicine & Life Sciences

1. Finland 100%
2. Prostatic Neoplasms 63%
3. Population 33%
4. Cohort Studies 31%
5. Child 29%
6. Neoplasms 27%
7. Incidence 26%
8. Therapeutics 25%
9. Mortality 24%
10. Randomized Controlled Trials 24%
11. Type 1 Diabetes Mellitus 23%
12. Confidence Intervals 22%
13. Quality of Life 22%
14. Survival 21%
15. Breast Neoplasms 21%
16. Asthma 20%
17. Wounds and Injuries 17%
18. Meta-Analysis 17%
19. Celiac Disease 17%
20. Registries 16%
21. Biomarkers 16%
22. Genes 16%
23. Stroke 14%
24. Prospective Studies 14%
25. Mothers 14%
26. Early Detection of Cancer 13%
27. Autoimmunity 13%
28. Prostate 12%
29. Genome-Wide Association Study 12%
30. Parturition 12%
31. Prostate-Specific Antigen 12%
32. Health 12%
33. Odds Ratio 12%
34. Blood Pressure 12%
35. Hip 12%
36. Pregnancy 12%
37. Systematic Reviews 12%
38. Autoantibodies 11%
39. Phenotype 11%
40. Multicenter Studies 11%
41. Serum 11%
42. Life Style 11%
43. Genome 11%
44. Brain Concussion 10%
45. Exercise 10%
46. Radiotherapy 10%
47. Arthroplasty 10%
48. Guidelines 10%
49. Placebos 10%
50. Mutation 10%
51. Observational Studies 10%
52. Pediatrics 10%
53. Delivery of Health Care 10%
54. Pandemics 10%
55. Carbonic Anhydrases 9%
56. Proteins 9%
57. Single Nucleotide Polymorphism 9%
58. Pre-Eclampsia 9%
59. Infections 9%
60. Castration 9%
61. DNA Methylation 9%
62. Inflammation 9%
63. Stem Cells 9%
64. Sweden 9%
65. Depression 9%
66. University Hospitals 9%
67. Blood Vessels 9%
68. Pain 9%
69. Uterine Cervical Neoplasms 9%
70. Spine 8%
71. Body Mass Index 8%
72. Smoking 8%
73. Obesity 8%
74. Traumatic Brain Injury 8%
75. Safety 8%
76. Androgens 8%
77. Enterovirus 8%
78. Recurrence 8%
79. Pharmaceutical Preparations 8%
80. Sleep 8%
81. Induced Pluripotent Stem Cells 8%
82. Avidin 7%
83. Genotype 7%
84. Hospital Emergency Service 7%
85. Lipids 7%
86. Retrospective Studies 7%
87. Colorectal Neoplasms 7%
88. Atherosclerosis 7%
89. Growth 7%
90. Neoplasm Metastasis 7%
91. Hantavirus Infections 7%
92. Drug Therapy 7%
93. Logistic Models 7%
94. Cross-Sectional Studies 7%
95. Biopsy 7%
96. Cardiac Myocytes 7%
97. Equipment and Supplies 7%
98. Databases 7%
99. Heart Rate 7%
100. Antibodies 6%